Fundraising FoxAthernal Bio
1 known investors
Find your way into Athernal Bio
Sign up to see every warm intro you have to Athernal Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Athernal Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Athernal Bio develops targeted immunotherapies for high-risk clonal haematopoiesis, a blood cancer precursor condition, with the goal of training the immune system to detect and eliminate mutated stem cells before blood cancers such as AML emerge. The company works in oncology/biotech, focusing on early therapeutic intervention for blood cancer precursor conditions.
Founders & leadership
LH
Louise HosieImmunology
Investors · 1
Frequently asked questions
- What does Athernal Bio do?
- Athernal Bio develops targeted immunotherapies for high-risk clonal haematopoiesis, a blood cancer precursor condition, with the goal of training the immune system to detect and eliminate mutated stem cells before blood cancers such as AML emerge. The company works in oncology/biotech, focusing on early therapeutic intervention for blood cancer precursor conditions.
- Who are Athernal Bio's investors?
- Athernal Bio's investors include Delin Ventures.